Yekaterina “Katie” Chudnovsky serves as General Counsel for an international technology firm, sits on the boards of four biotech and cancer research organizations, and chairs the GI Research Foundation at the University of Chicago. In 2025, the European School of Oncology named her one of the 100 Most Influential People in Oncology — a recognition earned through more than a decade of hands-on patient advocacy and research funding.
Born to Ukrainian immigrant parents and raised in the Chicago area, Katie Chudnovsky built her career at the intersection of law, venture capital, and medical philanthropy. Her husband, billionaire tech entrepreneur Leonid Radvinsky, passed away from cancer in March 2025. But her advocacy work in oncology predates that loss by years, rooted in a longstanding commitment to gastrointestinal and rare cancer research that has provided direct financial support to hundreds of patients.
Who Is Yekaterina “Katie” Chudnovsky?
Yekaterina Katie Chudnovsky is a Chicago-based attorney, venture investor, and cancer research advocate who has spent more than twelve years leading philanthropic initiatives in oncology and gastrointestinal disease. Her public profile has grown significantly since 2025, driven both by her oncology recognition and by media coverage following her husband Leonid Radvinsky’s death.
Early Life and the Name Yekaterina Katie Chudnovsky
Her given name, Yekaterina, reflects her family’s roots. She was born to Ukrainian immigrant parents and grew up in the Chicago metropolitan area — a city that would anchor nearly every phase of her education, career, and philanthropic life. Professionally, she goes by Katie Chudnovsky, though legal filings and board disclosures list her full name as Yekaterina Chudnovsky.
According to Crunchbase, she is also known as Kate Chudnovsky and maintains ties to both the Greater Miami Area and the Chicago region.
Katie Chudnovsky’s Religion and Personal Background
Searches for Katie Chudnovsky’s religion are common, but her faith is not part of her public record. She has not disclosed her religious affiliation in interviews, board biographies, or organizational profiles. What is documented is her Ukrainian heritage and her deep engagement with medical philanthropy — motivations she has framed in terms of patient advocacy rather than religious conviction.
Education: Northwestern University and DePaul University College of Law
Katie Chudnovsky holds a BA from Northwestern University and a JD from DePaul University College of Law — two institutions that cemented her professional foundation in Chicago’s legal and academic communities. Her academic credentials rarely appear in published profiles, making her educational background one of the least-documented aspects of her public identity.
Undergraduate Studies at Northwestern University
Northwestern University, a private research university in Evanston, Illinois, consistently ranks among the top 10 national universities. According to U.S. News & World Report, Northwestern emphasizes interdisciplinary learning — a framework reflected in Chudnovsky’s career bridging law, business, and biomedical philanthropy.
Law Degree from DePaul University College of Law
Her Juris Doctor comes from DePaul University College of Law, one of the oldest law schools in Illinois. DePaul’s intellectual property and technology law programs shaped her career focus on IP, trademarks, and technology licensing. The combination of a Northwestern BA and a DePaul JD positioned her for a General Counsel role overseeing IP strategy at a major technology firm.
Legal Career and Venture Investment in Chicago
Katie Chudnovsky serves as General Counsel for an international privately held technology firm, overseeing intellectual property, trademarks, and corporate technology strategy. She also operates as a venture investor with particular focus on early-stage biotech companies — a dual track that distinguishes her from the typical nonprofit board member profile.
From Attorney to General Counsel
Her legal career progressed from practicing attorney to General Counsel of an international technology company. According to her Elicio Therapeutics board profile, Chudnovsky oversees intellectual property, trademarks, and technology matters — responsibilities requiring both litigation-ready legal judgment and strategic business acumen in a sector where patent portfolios drive valuations.
| Role | Organization | Focus Area |
|---|---|---|
| General Counsel | International technology firm (private) | Intellectual property, trademarks, technology |
| Venture Investor | Independent | Early-stage biotech and oncology |
| Head of Special Projects | Rare Cancer Research Foundation | Cancer research funding and patient support |
Venture Investor and Biotech Board Member
Beyond her legal practice, Chudnovsky has established herself as a venture investor focused on biotech companies developing novel cancer therapies. Her board positions at Elicio Therapeutics and Immix Biopharma place her at the governance level of companies pursuing cutting-edge immunotherapy and oncology drug development.
Her legal background in IP — where evaluating patent claims demands rigorous analytical thinking — likely informs her investment thesis. Her Chicago base connects her to a Midwest biotech ecosystem anchored by the University of Chicago and Northwestern’s Feinberg School of Medicine.
Cancer Advocacy and Board Leadership
Katie Chudnovsky chairs the GI Research Foundation at the University of Chicago, serves on the board of the Colorectal Cancer Alliance, and leads special projects at the Rare Cancer Research Foundation — a portfolio of leadership roles spanning more than twelve years. In 2025, the European School of Oncology recognized her among the 100 Most Influential People in Oncology.
Chairperson of the GI Research Foundation at the University of Chicago
Chudnovsky served as President and Board Member of GIRF for twelve years before becoming Chairperson — a tenure that involved expanding research funding and connecting donors with clinical investigators at one of the nation’s top gastroenterology programs.
According to the Rare Cancer Research Foundation, her efforts at GIRF helped fund “countless research projects” and provided “financial support for hundreds of patients in need.”
Rare Cancer Research Foundation and the RCRF Role
At the Rare Cancer Research Foundation, Chudnovsky serves as Head of Special Projects. RCRF focuses on cancers that receive limited federal funding due to low prevalence — gastrointestinal, neuroendocrine, and sarcoma subtypes among them.
Rare cancers collectively account for roughly 27% of all cancer diagnoses in the United States, according to the National Cancer Institute, yet receive a disproportionately small share of research dollars. Chudnovsky’s RCRF role puts her at the center of filling that gap through targeted grants and patient support.
Board Memberships: Elicio Therapeutics, Immix Biopharma, Colorectal Cancer Alliance, and XCures
Chudnovsky’s board portfolio spans both nonprofit advocacy and for-profit biotech development:
| Organization | Type | Mission |
|---|---|---|
| Colorectal Cancer Alliance | Nonprofit | Patient advocacy and research funding for colorectal cancer |
| Elicio Therapeutics | Biotech (public) | Developing amphiphile-based immunotherapies for cancer |
| Immix Biopharma | Biotech (public) | Developing targeted cancer therapies including CAR-T treatments |
| XCures | Health tech | AI-driven platform matching cancer patients with clinical trials |
The Colorectal Cancer Alliance lists Chudnovsky on its Board of Directors alongside oncologists, corporate executives, and media figures including NBC journalist Craig Melvin. Her presence on both nonprofit boards (CCA, GIRF, RCRF) and commercial biotech boards (Elicio, Immix, XCures) gives her an unusually broad vantage point across the cancer research and treatment landscape.
Named Among the 100 Most Influential People in Oncology
In 2025, the European School of Oncology and Oncodaily recognized Yekaterina Katie Chudnovsky among the 100 Most Influential People in Oncology. The list honors individuals who “have helped shape current practice in oncology and continue to drive innovation” — criteria that typically favor researchers, oncologists, and policymakers rather than philanthropists.
Her inclusion signals that the oncology community views her contributions as substantive rather than ceremonial. Twelve years of GIRF leadership, direct patient funding through RCRF, and governance roles at companies developing novel cancer therapies collectively built the track record that earned this recognition.
Katie Chudnovsky and Leonid Radvinsky — Her Husband’s Life and Legacy
Katie Chudnovsky was married to Leonid Radvinsky, the billionaire majority owner of OnlyFans, for nearly two decades before his death from cancer in March 2025 at age 43. Their shared life in Chicago and his passing have driven significant public interest in her story — but her professional and philanthropic record stands entirely independent of that association.
Who Was Leonid Radvinsky?
Leonid Radvinsky was a Ukrainian-American tech entrepreneur based in Chicago who acquired a controlling stake in OnlyFans and previously operated MyFreeCams. Forbes and Bloomberg estimated his net worth in the billions, driven by OnlyFans’ explosive revenue growth. Despite that wealth, Radvinsky maintained an extremely private profile — rarely giving interviews. NBC News and the New York Post both reported on his death in March 2025.
Their Relationship and Shared Life in Chicago
Katie and Leonid Radvinsky shared a life in the Chicago area for nearly twenty years. Both came from Ukrainian immigrant families, and both built their careers in Chicago. While Leonid built his business empire, Katie developed her parallel career in law and cancer philanthropy — already deeply embedded in the oncology advocacy world long before his platform made global headlines.
Leonid Radvinsky’s Cancer Battle and Passing in March 2025
Leonid Radvinsky died in March 2025 at the age of 43 after what was described as a private battle with cancer. His death brought intense media scrutiny to his family and, inevitably, to Katie’s public profile.
The painful irony is hard to miss: a woman who spent more than a decade funding cancer research and supporting cancer patients lost her own husband to the disease. But reducing her advocacy to a reaction to personal tragedy would misrepresent the timeline. Her GIRF presidency, RCRF involvement, and board positions were all established before Radvinsky’s illness became public knowledge.
Katie Chudnovsky’s Age, Net Worth, and Online Presence
Katie Chudnovsky’s exact age, net worth, and social media presence rank among the most common questions about her — and among the least documented. Honest answers here require distinguishing between what is known, what can be reasonably inferred, and what remains private.
Katie Chudnovsky’s Age
Katie Chudnovsky’s exact birth year and age are not part of the public record. No organizational biography, board disclosure, or media profile includes her date of birth. Based on her educational timeline — a BA from Northwestern University followed by a JD from DePaul and a career spanning more than two decades — she is likely in her mid-to-late forties, but no confirmed figure exists.
Katie Chudnovsky’s Net Worth
No credible public estimate of Katie Chudnovsky’s independent net worth exists. Her income sources include a General Counsel salary, venture investment returns, and board compensation — but none of these figures are publicly disclosed for privately held firms.
Following Leonid Radvinsky’s death in March 2025, estate and inheritance considerations may significantly affect her financial profile, given his reported billionaire status. However, estate proceedings are typically private, and no verified financial disclosures have been published. Any specific net worth figure circulating online should be treated as speculation.
Katie Chudnovsky on Instagram and Social Media
Katie Chudnovsky does not appear to maintain a verified public Instagram account. Searches for “katie chudnovsky instagram” yield no confirmed profile. She does maintain a Medium blog where she has published writing, and Crunchbase lists a personal website at katechudnovsky.com. Her public digital footprint is otherwise limited to organizational board pages and professional directories — consistent with a pattern of deliberate privacy.
Frequently Asked Questions
Who is Katie Chudnovsky?
Katie Chudnovsky is a Chicago-based attorney, venture investor, and cancer research advocate whose full legal name is Yekaterina Chudnovsky. She serves as General Counsel for an international technology firm, chairs the GI Research Foundation at the University of Chicago, and sits on the boards of the Colorectal Cancer Alliance, Elicio Therapeutics, Immix Biopharma, and XCures.
Who was Katie Chudnovsky’s husband, Leonid Radvinsky?
Leonid Radvinsky was a Ukrainian-American tech entrepreneur and the billionaire majority owner of OnlyFans. He and Katie were married for nearly two decades and lived in the Chicago area. Radvinsky died in March 2025 at the age of 43 after a battle with cancer.
What is Yekaterina “Katie” Chudnovsky’s professional background?
Chudnovsky works as General Counsel for a privately held international technology company, where she oversees intellectual property, trademarks, and technology strategy. She is also a venture investor specializing in early-stage biotech and serves as Head of Special Projects at the Rare Cancer Research Foundation.
Where did Katie Chudnovsky go to school — did she attend Northwestern University?
Katie Chudnovsky earned her BA from Northwestern University in Evanston, Illinois, and her JD from DePaul University College of Law in Chicago. Both degrees are confirmed by her organizational biographies at the Rare Cancer Research Foundation and Elicio Therapeutics.
What boards does Katie Chudnovsky currently serve on?
She serves on the boards of the Colorectal Cancer Alliance, Elicio Therapeutics, Immix Biopharma, and XCures. She also chairs the GI Research Foundation at the University of Chicago, where she served as President and board member for twelve years before becoming Chairperson.
What is Katie Chudnovsky’s net worth?
No verified estimate of Katie Chudnovsky’s net worth has been publicly reported. Her income derives from a General Counsel role, venture investments, and board compensation, but specific figures are not disclosed. Following Leonid Radvinsky’s passing, estate considerations may affect her financial profile, though no public filings are available.
How old is Katie Chudnovsky?
Katie Chudnovsky’s exact age is not publicly documented. Based on her educational and career timeline, she is likely in her mid-to-late forties, but no confirmed birth year or date of birth appears in any organizational profile or media report.
Is Katie Chudnovsky on Instagram?
No verified public Instagram account for Katie Chudnovsky has been identified. She maintains a Medium blog at katechudnovsky.medium.com and has a personal website listed on Crunchbase, but her broader social media presence remains minimal and intentionally private.
What is Katie Chudnovsky’s religion?
Katie Chudnovsky’s religious affiliation is not part of her public record. She was born to Ukrainian immigrant parents and raised in the Chicago area, but she has not disclosed her faith in any organizational biography, interview, or public statement.
Why is Katie Chudnovsky involved in cancer research and advocacy?
Chudnovsky has been active in cancer research for over twelve years, beginning with the GI Research Foundation at the University of Chicago and expanding to the Rare Cancer Research Foundation and Colorectal Cancer Alliance. Her husband Leonid Radvinsky’s death from cancer in March 2025 added a personal dimension, but her advocacy was well established before that loss.
Conclusion
Katie Chudnovsky has built a career and philanthropic portfolio that speaks for itself: a Northwestern-educated, DePaul-trained attorney who rose to General Counsel, pivoted into venture investing in oncology biotech, and spent more than a decade chairing one of the University of Chicago’s key cancer research foundations. The 2025 recognition as one of oncology’s 100 most influential people reflects the cumulative weight of that work.
Her name entered broader public awareness through her marriage to Leonid Radvinsky and his death in 2025. But the record — twelve years at GIRF, board seats at four organizations, hundreds of patients supported through RCRF — predates and outlasts any single headline.
